Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
164,213,918
-
Shares change
-
+548,252
-
Total reported value, excl. options
-
$727,462,907
-
Value change
-
+$3,483,841
-
Put/Call ratio
-
0.11%
-
Number of buys
-
107
-
Number of sells
-
-111
-
Price
-
$4.43
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q4 2024
264 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q4 2024.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 164,213,918 shares
.
Largest 10 shareholders include BlackRock, Inc. (23,037,335 shares), VANGUARD GROUP INC (19,538,555 shares), Sarissa Capital Management LP (16,390,000 shares), Pacer Advisors, Inc. (11,730,771 shares), ARMISTICE CAPITAL, LLC (9,468,000 shares), RENAISSANCE TECHNOLOGIES LLC (9,066,241 shares), STATE STREET CORP (8,328,817 shares), BRAIDWELL LP (5,440,277 shares), Kynam Capital Management, LP (4,685,563 shares), and LSV ASSET MANAGEMENT (4,081,501 shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.